While they are not advised for all women, MRI (magnetic resonance imaging) scans are proving to be an effective diagnostic tool that enables physicians to pick up the very early signs of breast cancer (when they are used in conjunction with mammograms). Currently, this use of MRIs is recommended only for women with a strong family history of breast or ovarian cancer, and for those who carry a genetic mutation (known as BRCA1 or BRCA2), or who have already been diagnosed with the disease.
In terms of new treatment regimens, one that shows promise in clinical trials, though it is still experimental, is called accelerated partial breast irradiation. With this approach, radiation is delivered to a specific target area rather than the whole breast, using techniques such as 3-D conformal external beam radiation or brachytherapy (in which doctors implant radioactive sources into the breast). This shortened schedule of treatment, however, is only appropriate for women with early-stage cancers, in which tumors have been removed by lumpectomy and the cancer has not spread to the lymph nodes.
Typically, breast cancer patients undergo radiation treatments after a lumpectomy (in which the malignant tumor and a small amount of breast tissue surrounding it are removed) or sometimes after mastectomy (surgical removal of the whole breast). Unlike other whole-body cancer treatments, such as chemotherapy or hormonal therapy, radiation is a localized therapy confined to one part of the anatomy. To treat breast cancer, patients are positioned in a CT scanner to map out the best angles for protecting the lungs and heart from radiation; then, patients are usually exposed to a treatment beam for only one to two minutes per session.
Typically, breast cancer patients have been treated five days a week for five to seven weeks. Recently, however, Canadian research shows that three weeks of radiation treatment may be just as effective.
While not every breast cancer patient may be eligible for some of the new treatments, all women can benefit from breakthroughs in mammography technology. Today's digital mammograms and computer-aided diagnostic capabilities enable radiologists to pinpoint the areas of the breast needing surgical biopsy. Further, software used with digital mammograms makes it easier to identify subtle changes in breast tissue when a patient's mammograms are compared year to year.
Annual mammograms are recommended for women age 40 or older; and those in a high-risk category for breast cancer should not only schedule an annual mammogram, but also talk with their doctors about the benefits of an MRI scan as well.
This story contains 484 words.
If you are a paid subscriber, check to make sure you have logged in. Otherwise our system cannot recognize you as having full free access to our site.
If you are a paid print subscriber and haven't yet set up an online account, click here to get your online account activated.